Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07119229 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

Study acronym: IAB-2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 3 to 4
    • Eligibility criteria shortened, about 40 words
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Site details revised at 2 of 3 sitesv7
  3. Study sites: 4 to 3v6
  4. Recruitment opened
    • Study sites: 3 to 4
    • Start date changed from estimate of Mar 2026 to Mar 25, 2026
    v5
  5. Study sites: 2 to 3v4
Show 2 earlier versionsHide 2 earlier versions
  1. Phase: Phase 2 to Not applicable
    • Start date: Sep 2025 to Mar 2026
    • Study sites: 0 to 2
    • Primary completion date: Feb 2027 to Jul 2027
    v3
  2. Study title revisedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pulmair Medical, Inc.
3 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.
Trial Details
NCT Number NCT07119229
Lead Sponsor Pulmair Medical, Inc.
Conditions
(from sponsor)		 Emphysema or COPD, Emphysema, COPD
Related terms Emphysema, Pulmonary Disease, Chronic Obstructive
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov